seer.bio - Aset Bersih saben Siji Saham SEER

The price indicator on the Seer, Inc. (SEER) chart reflects the performance of the company, which develops high-precision systems for protein research. Production stability is ensured by a broad pool of electronics suppliers, which maintains the margin at 4.09. However, slow innovation adoption and massive R&D expenditures create financial risks. The business currently relies on grants and venture capital investments while awaiting a transition to stable self-sufficiency.

Ekuitas saben Saham Seer Inc (SEER): kanggo periode 04.07.2022 - 27.10.2026

Ringkesan rincian data analitis seer.bio (SEER)

- rega lan prakiraan konsensus rega:

Rega saham Seer Inc.|SEER - Rata-rata rega prakiraan

- data kapitalisasi pasar:

Nilai pasar Seer, Inc.|SEER - Nilai Dipunlarasaken Utang lan Kas

- data kapitalisasi buku:

Nilai Buku saben Saham Seer|SEER - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku seer.bio|SEER - Gunggung Aset Perusahaan

- data utang lan likuiditas:

Total Utang marang Modal Seer, Inc.|SEER - Utang jangka dawa marang modal|Utang jangka cendhak marang modal Seer|SEER - Tanggungan utang total perusahaan|Rasio utang marang kapitalisasi buku Seer, Inc.

Pambiji fundamental perusahaan:Seer, Inc.

Institutional capital assesses the attractiveness of Seer, Inc. (SEER) through the lens of equity minus all liabilities, which determines the intrinsic value of the business. By analyzing the book value per share, investors identify the net assets per security, which for this proteomics leader serves as the foundation for developing personalized medicine tools and a guarantee of stability amidst volatile operating revenues.

Analisis pesaing Seer, Inc.